KIR and HLA genotypes have no identifiable role in single unit dominance following double unit umbilical cord blood transplantation

Por Tarek, Nidale, Gallagher, Meighan M., Chou, Joanne F., Lubin, Marissa N., Heller, Glenn, Barker, Juliet N., Hsu, Katharine C.
Publicado no Bone Marrow Transplant (2014)

HLA-C–Dependent Prevention of Leukemia Relapse by Donor Activating KIR2DS1

Por Venstrom, Jeffrey M., Pittari, Gianfranco, Gooley, Ted A., Chewning, Joseph H., Spellman, Stephen, Haagenson, Michael, Gallagher, Meighan M., Malkki, Mari, Petersdorf, Effie, Dupont, Bo, Hsu, Katharine C.
Publicado em 2012

Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment

Por Tarek, Nidale, Le Luduec, Jean-Benoit, Gallagher, Meighan M., Zheng, Junting, Venstrom, Jeffrey M., Chamberlain, Elizabeth, Modak, Shakeel, Heller, Glenn, Dupont, Bo, Cheung, Nai-Kong V., Hsu, Katharine C.
Publicado em 2012

Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation

Por Sobecks Ronald, M, Tao, Wang, Medhat, Askar, Gallagher Meighan, M, Michael, Haagenson, Stephen, Spellman, Marcelo, Fernandez-Vina, Karl-Johan, Malmberg, Carlheinz, Muller, Minoo, Battiwalla, James, Gajewski, Verneris Michael, R, Olle, Ringden, Marino Susana, R, Stella, Davies, Jason, Dehn, Martin, Bornhäuser, Yoshihiro, Inamoto, Ann, Woolfrey, Peter, Shaw, Marilyn, Pollack, Daniel, Weisdorf, Jeffrey, Miller, Hurley Carolyn, K, Lee Stephanie, J, Hsu Katharine, C
Publicado no Biol Blood Marrow Transplant (2015)